Skip to main content

Table 5 Left ventricular outcomes versus HbA1c Categories: Adjusted Model. Reference HbA1c < 5.7%)

From: Glycemic status, non-traditional risk and left ventricular structure and function in the Jackson Heart Study

Left Ventricular Measures

HbA1c 5.7–< 6.5%

HbA1c 6.5–< 8.0%

HbA1c ≥ 8.0%

n

Mean difference

Percent parameter difference (95% CI)

Sig

Mean difference

Percent parameter difference (95% CI)

Sig

Mean difference

Percent parameter difference (95% CI)

Sig

Left Ventricular Ejection Fraction (%)

0.11

0.18 (− 1.00, 1.39)

0.763

− 1.34

− 2.18 (− 4.55, 0.25)

0.078

− 0.20

− 0.32 (− 2.69, 2.09)

0.787

2082

Left Ventricular Fractional Shortening (%)

− 0.39

− 1.02 (− 2.96, 0.97)

0.314

− 1.02

− 2.64 (− 6.63, 1.50)

0.208

− 0.51

− 1.34 (− 5.30, 2.79)

0.519

1512

Left Ventricular End Diastolic Volume (ml/m2)

− 1.19

− 2.25 (− 4.04, − 0.42)

0.016

− 1.45

− 2.75 (− 6.40, 1.05)

0.152

− 2.11

− 3.97 (− 7.47, − 0.34)

0.032

2082

Left Ventricular End Systolic Volume (ml/m2)

− 0.40

− 2.44 (− 5.53, 0.75)

0.133

− 0.20

1.25 (− 5.29, 8.23)

0.716

− 0.19

− 1.15 (− 7.34, 5.46)

0.726

2082

Stroke Volume Index (ml/m2)

− 0.75

− 2.13 (− 4.07, − 0.14)

0.036

− 1.74

− 4.84 (− 8.72, − 0.80)

0.020

− 2.09

− 5.81 (− 9.53, − 1.93)

0.004

2082

Cardiac Index (L/min/m2)

− 0.06

− 2.28 (− 4.49, − 0.02)

0.048

0.01

0.14 (− 4.49, 5.00)

0.952

0.11

4.85 (0.15, 9.78)

0.043

2082

Myocardial Contraction Fraction (%)

− 0.38

− 0.72 (− 2.80, 1.41)

0.507

− 1.19

− 2.21 (− 6.40, 2.15)

0.315

− 2.94

− 5.38 (− 9.32, − 1.26)

0.011

2082

Left Ventricular Mass Index (g/m2)

− 0.04

− 0.06 (− 2.14, 2.06)

0.953

− 0.71

− 1.01 (− 5.22, 3.39)

0.647

1.42

2.06 (− 2.15, 6.46)

0.341

2082

Relative Wall Thickness (cm)

 < 0.01

1.16 (− 0.53, 2.90)

0.180

 < 0.01

1.12 (− 2.36, 4.71)

0.533

0.01

3.73 (0.26, 7.32)

0.035

2082

  1. Each row represents a separate model for Left ventricular outcomes and were adjusted for diabetes duration, Hypertension age, gender, physical activity, highest level of education, nutrition pattern, dyslipidemia smoking status, alcohol use, use of crack or cocaine, carvedilol dose equivalent, calcium channel blockers, diuretics, Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blocker. Only LVEF, LV FS, MCF and RWT which were additionally controlled for log of BMI